Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein.
about
RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts.Atomic force microscopy investigation of isolated virions of murine leukemia virus.N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles.MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.Atomic force microscopy investigation of fibroblasts infected with wild-type and mutant murine leukemia virus (MuLV)Antiretroviral restriction factors in mice.Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo.Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms.Characterization of gP85gag as an antigen recognized by Moloney leukemia virus-specific cytolytic T cell clones that function in vivoA nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia virusesIdentification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus.Viral determinants that control the neuropathogenicity of PVC-211 murine leukemia virus in vivo determine brain capillary endothelial cell tropism of the virus in vitro.The R-U5-5' leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative diseaseHepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.Assembly of gag-beta-galactosidase proteins into retrovirus particles.Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesisMurine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.Generation of a recombinant Moloney murine leukemia virus carrying the v-src gene of avian sarcoma virus: transformation in vitro and pathogenesis in vivo.A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitroExpression of the precore region of an avian hepatitis B virus is not required for viral replication.Frequent hereditable shutdown of murine retrovirus gene expression in murine cell linesNucleic acid recognition orchestrates the anti-viral response to retroviruses.N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins.An RNA structural switch regulates diploid genome packaging by Moloney murine leukemia virus.Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release.Efficient marking of neural stem cell-derived neurons with a modified murine embryonic stem cell virus, MESV2.Defects in the precore region of hepatitis B virus DNA in a plasma pool from carriers seropositive for antibody against e antigen and with infectivity in chimpanzees.Full-Length Glycosylated Gag of Murine Leukemia Virus Can Associate With The Viral Envelope as a Type I Integral Membrane Protein.Ribosome profiling of the retrovirus murine leukemia virus.DDX41 Recognizes RNA/DNA Retroviral Reverse Transcripts and Is Critical for In Vivo Control of Murine Leukemia Virus Infection.
P2860
Q21090538-7C826701-80A7-4335-81D4-6FE022FD12A8Q33650603-C19914A3-6E44-4D75-8945-16C7C51A7146Q33667036-1055A1B5-EDF3-4B71-9965-0B4F6EDA4201Q33718287-32A0487F-E3E1-4E6F-98BC-8A038CA6869FQ33849448-346228F2-6D5B-4CA0-A9A9-8D556F6C665DQ33927183-366E53C4-0920-4DB3-9474-2450CE421FB7Q34179598-FEA7B1F5-317A-4F85-8370-3E46C0DAB3D6Q34623866-03D96B1B-9B5B-4A44-ACD1-D20322F78E94Q35888352-34D2233C-5116-4FF7-8DD6-9C5F228F64ADQ35927461-189DE26D-C468-4B5E-A8FD-4E693AA0980FQ36350428-7B31AB21-3DDB-49AC-BFF1-772399713632Q36634291-49D337D7-98E7-47B8-9787-2B3464E4A0A0Q36634317-C9A0478D-BBCB-411A-B8A7-CF574AAD831AQ36650903-2C99A490-6A31-4F6B-9F3F-2DCBB3FB0A9EQ36683978-CD990ACC-A772-4F01-B2A2-14F25FE643FAQ36802480-3CFA74A8-2B5E-4FAE-8B91-C9576B322499Q36805988-239F34E3-13EF-4124-8188-ECB4A8DF3C15Q36883505-F570B591-6709-47D8-A9BF-A17070DCF969Q36895829-79969C9B-F8DE-4DBB-AD23-3033F8E94C01Q36900374-D27413B4-495E-4329-BA63-319D62766332Q36902155-0E068F02-141B-42BE-A881-73307DF9313DQ36918746-49EF131F-7881-43D0-A92F-88BEAF6A95C1Q36919460-E8A1BA36-E224-4D80-B83F-EA04E820C1A6Q36944466-E91B6C7C-2260-443B-B7CF-F633A6CCD7F3Q38894113-FA906087-BD6D-46F9-97F1-D7F90985E2ECQ38928610-02AD7EBE-5CD7-46EC-B744-0854C7785000Q39553970-1AB90385-3201-495C-94D0-236A1951EF5DQ40176579-61140174-961F-4771-9DEC-06FF299D4593Q45731859-F2C01A68-3DF2-4DBE-8BAE-311820326C35Q45852115-E34B2DB9-6998-4A99-99E5-C29D9FD7E1CFQ47234345-34F90644-ABE6-4EA5-B071-798D361013F8Q47550286-BDD65611-8A76-4CC1-A5CE-84BCD772C728Q55207475-912A7BE5-784E-4356-B537-B2E9209327B7
P2860
Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Construction and characterizat ...... glycosylated gag polyprotein.
@en
Construction and characterizat ...... glycosylated gag polyprotein.
@nl
type
label
Construction and characterizat ...... glycosylated gag polyprotein.
@en
Construction and characterizat ...... glycosylated gag polyprotein.
@nl
prefLabel
Construction and characterizat ...... glycosylated gag polyprotein.
@en
Construction and characterizat ...... glycosylated gag polyprotein.
@nl
P2093
P2860
P356
P1476
Construction and characterizat ...... glycosylated gag polyprotein.
@en
P2093
P2860
P304
P356
10.1073/PNAS.80.19.5965
P407
P577
1983-10-01T00:00:00Z